Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease

被引:189
作者
Francis, SE
Camp, NJ
Dewberry, RM
Gunn, J
Syrris, P
Carter, ND
Jeffery, S
Kaski, JC
Cumberland, DC
Duff, GW
Crossman, DC
机构
[1] Univ Sheffield, Div Clin Sci, Sheffield S10 2TN, S Yorkshire, England
[2] Univ Sheffield, Div Med & Mol Genet, Sheffield S10 2TN, S Yorkshire, England
[3] St George Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England
关键词
interleukins; genes; coronary artery disease;
D O I
10.1161/01.CIR.99.7.861
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Cytokine gene variations are contributory factors in inflammatory pathology. Allele frequencies of interleukin (IL)-1 cluster genes [IL-1A(-889), IL-1B(-511), IL-1B(+3953), IL-1RN Intron 2 VNTR] and tissue necrosis factor (TNF)-alpha gene [TNFA(-308)] were measured in healthy blood donors (healthy control subjects), patients with angiographically normal coronary arteries (patient control subjects), single-vessel coronary disease (SVD), and those with multivessel coronary disease (MVD). Methods and Results-Five hundred fifty-six patients attending for coronary angiography in Sheffield were studied: 130 patient control subjects, 98 SVD, and 328 MVD. Significant associations were tested in an independent population (London) of 350: 57 SVD, 191 MVD, and 102 control subjects. IL-1RN*2 frequency in Sheffield patient control subjects was the same as in 827 healthy control subjects. IL-1RN*2 was significantly overrepresented in Sheffield SVD patients (34% vs 23% in patient control subjects); IL-1RN*2 homozygotes in the SVD population (chi(2) carriage=8.490, 1 df, P=0.0036). This effect was present though not quite significant in the London population (P=0.0603). A summary trend test of the IL-1RN SVD genotype data for Sheffield and London showed a significant association with *2 (P=0.0024). No significant effect of genotype at TL-1RN was observed in the Sheffield or London MVD populations. Genotype distribution analysis comparing the SVD and MVD populations at TL-1RN showed a highly significant trend (P=0.0007) with the use of pooled data. No significant associations were seen for the other polymorphisms. Conclusions-IL-1RN*2 was significantly associated with SVD. A difference in genetic association between SVD and MVD was also apparent.
引用
收藏
页码:861 / 866
页数:6
相关论文
共 46 条
[1]   INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :167-227
[2]   DETECTION AND LOCALIZATION OF TUMOR NECROSIS FACTOR IN HUMAN ATHEROMA [J].
BARATH, P ;
FISHBEIN, MC ;
CAO, J ;
BERENSON, J ;
HELFANT, RH ;
FORRESTER, JS .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (05) :297-302
[3]   INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
COTRAN, RS ;
GIMBRONE, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :618-623
[4]  
Blakemore AIF, 1996, HUM GENET, V97, P369, DOI 10.1007/BF02185776
[5]   ADHESION OF HUMAN BASOPHILS, EOSINOPHILS, AND NEUTROPHILS TO INTERLEUKIN 1-ACTIVATED HUMAN VASCULAR ENDOTHELIAL-CELLS - CONTRIBUTIONS OF ENDOTHELIAL-CELL ADHESION MOLECULES [J].
BOCHNER, BS ;
LUSCINSKAS, FW ;
GIMBRONE, MA ;
NEWMAN, W ;
STERBINSKY, SA ;
DERSEANTHONY, CP ;
KLUNK, D ;
SCHLEIMER, RP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) :1553-1556
[6]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[7]  
Cork M J, 1995, J Invest Dermatol, V104, p15S
[8]   An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers [J].
Cox, A ;
Camp, NJ ;
Nicklin, MJH ;
di Giovine, FS ;
Duff, GW .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (05) :1180-1188
[9]  
DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303
[10]  
DIGIOVINE FS, 1990, IMMUNOL TODAY, V11, P13